AF and Stroke Prevention
New data confirms that the Boston Scientific WATCHMAN™ Left Atrial Appendage Closure Device is safe and effective in reducing the risk of stroke in patients deemed unsuitable for oral anticoagulation - May 18, 2017
One-year data from the EWOLUTION registry found that left atrial appendage closure (LAAC) with the WATCHMAN™ device followed by dual antiplatelet therapy (DAPT) significantly...
New data from the EWOLUTION registry presented at EuroPCR 2016 confirms safety of the Boston Scientific WATCHMAN™ Left Atrial Appendage Closure device
May 17, 2016
Three-months outcomes on more than 1000 patients across Europe focus on post-procedural drug regimen, impact of centre experience and peri-device leakage.
SEE ALL PRESS RELEASES
